Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103346905> ?p ?o ?g. }
- W2103346905 endingPage "232" @default.
- W2103346905 startingPage "226" @default.
- W2103346905 abstract "Objective To describe and analyze observed hypersensitivity reactions (HSR) from the randomized, multicenter phase III CALYPSO trial that evaluated the efficacy and safety of the combination of carboplatin and pegylated liposomal doxorubicin (CD) compared with standard carboplatin–paclitaxel (CP) in patients with platinum-sensitive relapsed ovarian cancer (ROC). Methods HSR documented within case report forms and SAE reports were specifically analyzed. Analyses were based on the population with allergy of any grade and for grade >2 allergy. Results Overall 976 patients were recruited to this phase III trial, with toxicity data available for 466 and 502 on the CD and CP arms, respectively. There was a 15.5% HSR rate associated with CD (2.4% grade >2) versus 33.1% with CP (8.8% grade >2), p<0.001. HSRs occurred more often during first cycle in the CD (46%) arm than in the CP arm (16%). Multivariate predictors of allergy were chemotherapy regimen and age; patients randomized to CD and patients≥70 years old on CP had less allergy. Few patients (<6%) stopped treatment due to allergy. Allergy rates were higher in patients who did not receive prior supportive treatment; however there was no relationship between allergy and the type of carboplatin product received, or response rate. Conclusions Use of PLD with carboplatin instead of paclitaxel and older age were the only 2 factors predicting a low rate of HSRs in patients with ROC. CD has previously demonstrated superior progression-free survival and therapeutic index than CP. Taken together these data support the use of CD as a safe and effective therapeutic option for platinum-sensitive ROC." @default.
- W2103346905 created "2016-06-24" @default.
- W2103346905 creator A5014722961 @default.
- W2103346905 creator A5018539503 @default.
- W2103346905 creator A5030229940 @default.
- W2103346905 creator A5035737899 @default.
- W2103346905 creator A5042461515 @default.
- W2103346905 creator A5042726718 @default.
- W2103346905 creator A5044628363 @default.
- W2103346905 creator A5058535647 @default.
- W2103346905 creator A5064285549 @default.
- W2103346905 creator A5067146231 @default.
- W2103346905 creator A5073063132 @default.
- W2103346905 creator A5073713547 @default.
- W2103346905 creator A5086083902 @default.
- W2103346905 date "2011-08-01" @default.
- W2103346905 modified "2023-09-30" @default.
- W2103346905 title "Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: Analysis from the GCIG CALYPSO relapsing ovarian cancer trial" @default.
- W2103346905 cites W120771606 @default.
- W2103346905 cites W1863225814 @default.
- W2103346905 cites W1893282660 @default.
- W2103346905 cites W1910585037 @default.
- W2103346905 cites W1965918908 @default.
- W2103346905 cites W1968779216 @default.
- W2103346905 cites W1970532901 @default.
- W2103346905 cites W1977134724 @default.
- W2103346905 cites W1994267136 @default.
- W2103346905 cites W2005915030 @default.
- W2103346905 cites W2008745570 @default.
- W2103346905 cites W2013117769 @default.
- W2103346905 cites W2017801815 @default.
- W2103346905 cites W2020365691 @default.
- W2103346905 cites W2024075406 @default.
- W2103346905 cites W2026361533 @default.
- W2103346905 cites W2036177573 @default.
- W2103346905 cites W2036846599 @default.
- W2103346905 cites W2037018314 @default.
- W2103346905 cites W2038033170 @default.
- W2103346905 cites W2038998118 @default.
- W2103346905 cites W2044725535 @default.
- W2103346905 cites W2057716223 @default.
- W2103346905 cites W2060522388 @default.
- W2103346905 cites W2063953472 @default.
- W2103346905 cites W2067361585 @default.
- W2103346905 cites W2070957637 @default.
- W2103346905 cites W2073739889 @default.
- W2103346905 cites W2079269416 @default.
- W2103346905 cites W2082847138 @default.
- W2103346905 cites W2087094124 @default.
- W2103346905 cites W2089356078 @default.
- W2103346905 cites W2103799380 @default.
- W2103346905 cites W2112687126 @default.
- W2103346905 cites W2118034823 @default.
- W2103346905 cites W2124140010 @default.
- W2103346905 cites W2134158593 @default.
- W2103346905 cites W2138035969 @default.
- W2103346905 cites W2138100326 @default.
- W2103346905 cites W2144841365 @default.
- W2103346905 cites W2161782921 @default.
- W2103346905 cites W2162570207 @default.
- W2103346905 cites W2170179169 @default.
- W2103346905 cites W4210704032 @default.
- W2103346905 cites W4230103308 @default.
- W2103346905 doi "https://doi.org/10.1016/j.ygyno.2011.04.019" @default.
- W2103346905 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21575983" @default.
- W2103346905 hasPublicationYear "2011" @default.
- W2103346905 type Work @default.
- W2103346905 sameAs 2103346905 @default.
- W2103346905 citedByCount "56" @default.
- W2103346905 countsByYear W21033469052012 @default.
- W2103346905 countsByYear W21033469052013 @default.
- W2103346905 countsByYear W21033469052014 @default.
- W2103346905 countsByYear W21033469052015 @default.
- W2103346905 countsByYear W21033469052016 @default.
- W2103346905 countsByYear W21033469052017 @default.
- W2103346905 countsByYear W21033469052018 @default.
- W2103346905 countsByYear W21033469052019 @default.
- W2103346905 countsByYear W21033469052020 @default.
- W2103346905 countsByYear W21033469052021 @default.
- W2103346905 countsByYear W21033469052022 @default.
- W2103346905 countsByYear W21033469052023 @default.
- W2103346905 crossrefType "journal-article" @default.
- W2103346905 hasAuthorship W2103346905A5014722961 @default.
- W2103346905 hasAuthorship W2103346905A5018539503 @default.
- W2103346905 hasAuthorship W2103346905A5030229940 @default.
- W2103346905 hasAuthorship W2103346905A5035737899 @default.
- W2103346905 hasAuthorship W2103346905A5042461515 @default.
- W2103346905 hasAuthorship W2103346905A5042726718 @default.
- W2103346905 hasAuthorship W2103346905A5044628363 @default.
- W2103346905 hasAuthorship W2103346905A5058535647 @default.
- W2103346905 hasAuthorship W2103346905A5064285549 @default.
- W2103346905 hasAuthorship W2103346905A5067146231 @default.
- W2103346905 hasAuthorship W2103346905A5073063132 @default.
- W2103346905 hasAuthorship W2103346905A5073713547 @default.
- W2103346905 hasAuthorship W2103346905A5086083902 @default.
- W2103346905 hasConcept C121608353 @default.
- W2103346905 hasConcept C126322002 @default.
- W2103346905 hasConcept C141071460 @default.